Enavogliflozin Outcome Trial in Functional Tricuspid Regurgitation
Enavogliflozin Outcome Trial in Functional Tricuspid Regurgitation
Active, not recruiting · NCT06027307 · Registry updated 2025-12-29Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Enavogliflozin Outcome Trial in Functional Tricuspid Regurgitation | cardiovascular disorder, heart disorder, heart valve disorder, tricuspid valve insufficiency | Active, not recruiting | Phase 3 | 2025-12-29 | NCT06027307 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Asan Medical Center | 114 |
| Daewoong Pharmaceutical Co. LTD. | 38 |
5 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Asan Medical Center | Seoul | South Korea | 131 |
| Inha University Hospital | Incheon | South Korea | 21 |
| Samsung Medical Center | Seoul | South Korea | 170 |
| Seoul National University Hospital | Seoul | South Korea | 183 |
| Yonsei University Medical Center | Seoul | South Korea | 2 |